In Brief: Novoste BERT-1.5 trial
This article was originally published in The Gray Sheet
Executive Summary
Novoste BERT-1.5 trial: Enrollment of 60 patients is complete in the firm's international Beta Energy Restenosis Trial (BERT-1.5) feasibility trial of its beta-emitting Beta-Cath catheter system for restenosis treatment, the firm reports Dec. 12. Data from a 35-patient U.S. pilot study, BERT-1, were reported in November at the American Heart Association annual meeting in Orlando, Florida ("The Gray Sheet" Nov. 17, In Brief). To date, 85 patients have been enrolled in the firm's randomized, placebo-controlled, multi-site trial, in which the company eventually expects to enroll 1,100 patients...